Liesel M FitzGerald

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. pmc Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer
    Liesel M FitzGerald
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA
    BMC Cancer 8:230. 2008
  2. pmc Genome-wide linkage analyses of hereditary prostate cancer families with colon cancer provide further evidence for a susceptibility locus on 15q11-q14
    Liesel M FitzGerald
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Eur J Hum Genet 18:1141-7. 2010
  3. pmc Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression
    Liesel M FitzGerald
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Hum Mutat 34:149-56. 2013
  4. pmc Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibility
    Liesel M FitzGerald
    Division of Public Health Sciences, University of Washington, Seattle, Washington, USA
    Cancer Epidemiol Biomarkers Prev 22:1520-8. 2013
  5. pmc Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk
    Claudia A Salinas
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Am J Epidemiol 172:578-90. 2010
  6. pmc Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer
    Liesel M FitzGerald
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 20:1196-203. 2011
  7. pmc Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality
    Daniel W Lin
    Department of Urology, University of Washington School of Medicine, Seattle, WA, USA
    Cancer Epidemiol Biomarkers Prev 20:1928-36. 2011
  8. pmc Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage
    Janet L Stanford
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Hum Mol Genet 18:1839-48. 2009

Collaborators

Detail Information

Publications8

  1. pmc Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer
    Liesel M FitzGerald
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA
    BMC Cancer 8:230. 2008
    ..These associations suggest the hypothesis that the gene fusion may be used as a prognostic indicator for prostate cancer...
  2. pmc Genome-wide linkage analyses of hereditary prostate cancer families with colon cancer provide further evidence for a susceptibility locus on 15q11-q14
    Liesel M FitzGerald
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Eur J Hum Genet 18:1141-7. 2010
    ..This study shows the benefit of using a comprehensive family cancer history to create more genetically homogenous subsets of HPC families for linkage analyses...
  3. pmc Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression
    Liesel M FitzGerald
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Hum Mutat 34:149-56. 2013
    ..These data indicate that the increase in PC risk associated with rs10993994:C>T is likely mediated by the variant's effect on PSP94 expression; however, this effect does not extend to NCOA4 in the data presented here...
  4. pmc Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibility
    Liesel M FitzGerald
    Division of Public Health Sciences, University of Washington, Seattle, Washington, USA
    Cancer Epidemiol Biomarkers Prev 22:1520-8. 2013
    ..Rare, inherited mutations account for 5% to 10% of all prostate cancer cases. However, to date, few causative mutations have been identified...
  5. pmc Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk
    Claudia A Salinas
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Am J Epidemiol 172:578-90. 2010
    ..These results contribute further evidence that aspirin may have chemopreventive activity against prostate cancer and highlight the need for additional research...
  6. pmc Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer
    Liesel M FitzGerald
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 20:1196-203. 2011
    ..We therefore undertook a search for genetic variants associated with risk of more aggressive disease...
  7. pmc Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality
    Daniel W Lin
    Department of Urology, University of Washington School of Medicine, Seattle, WA, USA
    Cancer Epidemiol Biomarkers Prev 20:1928-36. 2011
    ..The purpose of this study was to test whether variation in selected candidate genes in biological pathways of interest for prostate cancer progression could help distinguish patients at higher risk for fatal prostate cancer...
  8. pmc Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage
    Janet L Stanford
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Hum Mol Genet 18:1839-48. 2009
    ....